Also trades as: AMYT.L (LSE) · $vol 0M
AMYT NASDAQ
Amryt Pharma plc
1W: +0.0%
1M: +0.7%
3M: +0.2%
1Y: +94.4%
$14.70
Last traded 2023-04-21 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$16M
-42.2% ▼
Capital Expenditures
$2M
+37.3% ▲
5Y CAGR: +161.6%
Free Cash Flow
$14M
-42.7% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$6M
-111.2% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$31M | -$29M | -$66M | -$105M | -$18M |
| Depreciation & Amort. | $311K | $355K | $13M | $44M | $51M |
| Stock-Based Comp. | $678K | $794K | $841K | $5M | $8M |
| Change in Working Capital | $2M | $1M | -$12M | -$4M | -$8M |
| Other Non-Cash Items | $14M | $12M | $28M | $87M | -$4M |
| Operating Cash Flow | -$14M | -$15M | -$37M | $27M | $16M |
| — Investing Activities — | |||||
| Capital Expenditures | -$396K | -$229K | -$652K | -$2M | -$2M |
| Acquisitions (Net) | $0 | $0 | $25M | $0 | $108M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $17K | -$14K | $92K | $87K | $5K |
| Investing Cash Flow | -$379K | -$243K | $24M | -$2M | $106M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $29M | $3M | $66M | $26M | -$125M |
| Financing Cash Flow | $29M | $3M | $66M | $26M | -$125M |
| Net Change in Cash | -$2M | -$12M | $56M | $52M | -$6M |
| Cash End of Period | $8M | $11M | $67M | $119M | $113M |
| Free Cash Flow | -$15M | -$15M | -$38M | $24M | $14M |